Literature DB >> 4655823

The role of the gut flora in the metabolism of cyclamate.

B S Drasar, A G Renwick, R T Williams.   

Abstract

1. [(14)C]Cyclamate was not metabolized when incubated with the liver, spleen, kidney or blood of rats of rabbits kept on a cyclamate-containing diet, and that had become converters of cyclamate into cyclohexylamine. 2. [(14)C]Cyclamate was converted into cyclohexylamine when incubated under anaerobic conditions with the contents of the caecum, colon or rectum or with the faeces of cyclamate-pretreated rats. Similar results were obtained with cyclamate-pretreated rabbits. With cyclamate-pretreated guinea pigs, which did not readily convert cyclamate into cyclohexylamine, the colon contents showed only low activity in this respect. 3. The faeces of a human converter of [(14)C]cyclamate into cyclohexylamine were also very active, but became less active when cyclamate was removed from his diet. 4. On subculturing the organisms from the contents of the colon and rectum of rats, the ability to convert cyclamate into cyclohexylamine was lost during three subcultures, but the loss of the activity was considerably decreased by subculturing in the presence of cyclamate. 5. Incubation of rat faeces in broths containing cyclamate increased their ability to metabolize cyclamate, but similar treatment of rabbit and human faeces suppressed this activity. 6. When rats are kept on a cyclamate diet the number of clostridia in the faeces increased considerably. In human dietary cyclamate did not appear to alter the counts of various faecal micro-organisms. 7. The gut organisms that appear to develop the ability to convert cyclamate into cyclohexylamine are clostridia in rats, enterobacteria in rabbits and enterococci in man. 8. [(14)C]Cyclohexylamine injected into the caecum or colon of rats is readily absorbed and excreted in the urine. 9. It appears that on continued intake of cyclamate the gut flora develop the ability to convert cyclamate into cyclohexylamine, which is then absorbed and excreted mainly in the urine, although a small proportion is metabolized to other compounds.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4655823      PMCID: PMC1174233          DOI: 10.1042/bj1290881

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  15 in total

1.  Rapid destruction of bacteria in commonly used diluents and its elimination.

Authors:  R P STRAKA; J L STOKES
Journal:  Appl Microbiol       Date:  1957-01

2.  Studies on synthetic sweetening agents. 13. Metabolism of sodium cyclamate. (2). Detection of metabolites of sodium cyclamate in the rabbit and rat by gas-liquid chromatography.

Authors:  S Kojima; H Ichibagase
Journal:  Chem Pharm Bull (Tokyo)       Date:  1968-09       Impact factor: 1.645

3.  The metabolism of cyclamates in rats.

Authors:  W C Wallace; E J Lethco; E A Brouwer
Journal:  J Pharmacol Exp Ther       Date:  1970-11       Impact factor: 4.030

4.  Excretion of cyclohexylamine in subjects ingesting sodium cyclamate.

Authors:  T R Davis; N Adler; J C Opsahl
Journal:  Toxicol Appl Pharmacol       Date:  1969-07       Impact factor: 4.219

5.  Cyclohexylamine excretors among human volunteers given cyclamate.

Authors:  J S Leahy; T Taylor; C J Rudd
Journal:  Food Cosmet Toxicol       Date:  1967-10

6.  Bacteria and aetiology of cancer of large bowel.

Authors:  M J Hill; B S Drasar; G Hawksworth; V Aries; J S Crowther; R E Williams
Journal:  Lancet       Date:  1971-01-16       Impact factor: 79.321

7.  Studies on synthetic sweetening agents. 8. Cyclohexylamine, a metabolite of sodium cyclamate.

Authors:  S Kojima; H Ichibagase
Journal:  Chem Pharm Bull (Tokyo)       Date:  1966-09       Impact factor: 1.645

8.  The fate of cyclamate in man and other species.

Authors:  A G Renwick; R T Williams
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

9.  Bladder tumors in rats fed cyclohexylamine or high doses of a mixture of cyclamate and saccharin.

Authors:  J M Price; C G Biava; B L Oser; E E Vogin; J Steinfeld; H L Ley
Journal:  Science       Date:  1970-02-20       Impact factor: 47.728

10.  THE DEVELOPMENT OF THE BACTERIAL FLORA IN THE GASTROINTESTINAL TRACT OF MICE.

Authors:  R W SCHAEDLER; R DUBOS; R COSTELLO
Journal:  J Exp Med       Date:  1965-07-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Contributions of gnotobiology to nutrition science.

Authors:  H Haenel; J Schulze
Journal:  Folia Microbiol (Praha)       Date:  1979       Impact factor: 2.099

Review 2.  Benefit and mischief from commensal bacteria.

Authors:  R E Williams
Journal:  J Clin Pathol       Date:  1973-11       Impact factor: 3.411

3.  Pharmacokinetics, cardiovascular and metabolic actions of cyclohexylamine in man.

Authors:  M Eichelbaum; J H Hengstmann; H D Rost; T Brecht; H J Dengler
Journal:  Arch Toxikol       Date:  1974-02-28

4.  The fate of cyclamate in man and other species.

Authors:  A G Renwick; R T Williams
Journal:  Biochem J       Date:  1972-10       Impact factor: 3.857

5.  Studies of the free faecal amines of infants with gastroenteritis and of healthy infants.

Authors:  K E Murray; R F Adams; J W Earl; K J Shaw
Journal:  Gut       Date:  1986-10       Impact factor: 23.059

6.  Influence of diets high and low in animal fat on bowel habit, gastrointestinal transit time, fecal microflora, bile acid, and fat excretion.

Authors:  J H Cummings; H S Wiggins; D J Jenkins; H Houston; T Jivraj; B S Drasar; M J Hill
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

Review 7.  The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism.

Authors:  Peter Spanogiannopoulos; Elizabeth N Bess; Rachel N Carmody; Peter J Turnbaugh
Journal:  Nat Rev Microbiol       Date:  2016-03-14       Impact factor: 60.633

Review 8.  Artificial sweeteners - a review.

Authors:  Sanchari Chattopadhyay; Utpal Raychaudhuri; Runu Chakraborty
Journal:  J Food Sci Technol       Date:  2011-10-21       Impact factor: 2.701

9.  High-dose saccharin supplementation does not induce gut microbiota changes or glucose intolerance in healthy humans and mice.

Authors:  Joan Serrano; Kathleen R Smith; Audra L Crouch; Vandana Sharma; Fanchao Yi; Veronika Vargova; Traci E LaMoia; Lydia M Dupont; Vanida Serna; Fenfen Tang; Laisa Gomes-Dias; Joshua J Blakeslee; Emmanuel Hatzakis; Scott N Peterson; Matthew Anderson; Richard E Pratley; George A Kyriazis
Journal:  Microbiome       Date:  2021-01-12       Impact factor: 14.650

10.  Untargeted metabolomics for uncovering plasma biological markers of wet age-related macular degeneration.

Authors:  Yanhui Deng; Ping Shuai; Haixin Wang; Shanshan Zhang; Jie Li; Mingyan Du; Peirong Huang; Chao Qu; Lulin Huang
Journal:  Aging (Albany NY)       Date:  2021-05-04       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.